Phase I trial investigating the safety, tolerability, and pharmacokinetics of single and repeat intravenous doses of BC 3781 in volunteers
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2010
At a glance
- Drugs Lefamulin (Primary)
- Indications Bacterial infections; Community-acquired pneumonia; Respiratory tract infections; Skin and soft tissue infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Nabriva Therapeutics
- 12 Apr 2010 Reference added for Nabriva Therapeutics media release reporting results presented at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2010).
- 11 Apr 2010 New trial record.